IDH1 mutation molecular subtypes and Proneural histological types were significantly associated with better survival in glioblastoma, whereas IDH1 wild molecular subtypes and Mesenchymal histological types were significantly associated with worse clinical outcome (25, 26). Here, IDH1 is linked to glioblastoma.